Historic Net Cash Flow for Nuvation Bio (NUVB) over the last 5 years, with Jun 2025 value amounting to $200.1 million.
- Nuvation Bio's Net Cash Flow rose 66146.53% to $200.1 million in Q2 2025 from the same period last year, while for Jun 2025 it was $213.3 million, marking a year-over-year increase of 1444.98%. This contributed to the annual value of -$7.4 million for FY2024, which is 87.38% up from last year.
- Nuvation Bio's Net Cash Flow amounted to $200.1 million in Q2 2025, which was up 1,553.48% from $12.1 million recorded in Q1 2025.
- In the past 5 years, Nuvation Bio's Net Cash Flow registered a high of $609.1 million during Q1 2021, and its lowest value of -$212.2 million during Q4 2021.
- Its 3-year average for Net Cash Flow is $14.6 million, with a median of $2.1 million in 2024.
- Its Net Cash Flow has fluctuated over the past 5 years, first tumbled by 7,901.26% in 2021, then skyrocketed by 66,146.53% in 2025.
- Nuvation Bio's Net Cash Flow (Quarterly) stood at -$212.2 million in 2021, then spiked by 82.29% to -$37.6 million in 2022, then skyrocketed by 148.56% to $18.3 million in 2023, then slumped by 74.96% to $4.6 million in 2024, then soared by 66,146.53% to $200.1 million in 2025.
- Its Net Cash Flow stands at $200.1 million for Q2 2025, versus $12.1 million for Q1 2025 and $4.6 million for Q4 2024.
